Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling
about
A new insight into hepatitis C vaccine developmentSIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathwaysCactin targets the MHC class III protein IkappaB-like (IkappaBL) and inhibits NF-kappaB and interferon-regulatory factor signaling pathwaysInteraction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responsesHepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functionsThe ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signalingVaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANKNegative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinaseSIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signalingISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral responseActivation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific mannerInnate immune recognition of viral infectionInhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.Sendai virus infection induces efficient adaptive immunity independently of type I interferonsThe myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transductionInhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanismsRegulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-IActivation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunityMany stimuli pull the necrotic trigger, an overviewPathogen recognition and inflammatory signaling in innate immune defensesLPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIFGB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVSToll-like receptor downstream signaling.Immunity to Pathogens Taught by Specialized Human Dendritic Cell SubsetsToll-like receptor activation: from renal inflammation to fibrosisMolecular and cellular regulation of toll-like receptor-4 activity induced by lipopolysaccharide ligandsThe effects of TLR activation on T-cell development and differentiationInnate immune signaling in defense against intestinal microbesToll-like receptors in antiviral innate immunityTLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetesA Family of Salmonella Type III Secretion Effector Proteins Selectively Targets the NF-κB Signaling Pathway to Preserve Host HomeostasisForeign RNA induces the degradation of mitochondrial antiviral signaling protein (MAVS): the role of intracellular antiviral factorsInterfering with interferons: Hepatitis C virus counters innate immunity.West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling.Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expressionUbiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virusWest Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKRDifferential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infectionWest Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal Transduction
P2860
Q21296858-09C15C94-7E82-4310-A216-0BC6670C804AQ24294536-3B5961CA-BC3D-4A71-ADF4-887E6AB9F909Q24299247-287E2C2C-2C73-47F9-AA9E-AA6AF332D309Q24300398-FD7E4CAD-101B-4088-89AE-A341D990B884Q24301741-7979DE8C-3FAB-4878-B111-CF663A4DCB62Q24305839-22947912-6C43-4003-973D-0D0C523A42A6Q24306761-8E22379C-C6C3-4391-BE9F-EBF4A8B79207Q24310727-111CB9F9-BE25-44B0-B8BF-0966F011E3F0Q24315702-F1F00B42-AA05-4E8C-8836-7522431DF40FQ24316441-B530EB00-FAE2-4593-B73B-0D60C9DDD70AQ24322120-0BBF8DEB-C35C-454F-9F8C-CEA59E859F3DQ24337029-32812BDA-36E9-4608-8BEA-CEF163A9DD72Q24498364-CFB13BF8-C7EB-4F67-9306-0938D2AC3BD4Q24519072-E784B71F-D8FA-4D10-894C-D2C075AEA922Q24545838-A5B37F2B-91D7-4CC0-A07F-0E090FAABA39Q24546498-27925810-2434-4814-870C-343C9F0BB851Q24548483-566EB8EF-A953-4209-88A7-311B1305F872Q24556673-9F2EB021-19BC-4A48-9F07-222933DDFCDDQ24562025-1CDAAF7E-9264-41EB-9EA9-7A298F525FA9Q24613714-639E18C1-B53F-4AD2-9BB3-65E2BA2BA848Q24643034-32470736-1A24-4CA5-9BAF-B11A64D3ED7FQ24672442-26234B87-DDEE-48F8-971F-3DE33CB7B271Q24675888-9484CEA2-7356-410A-81AA-184A6AC3D002Q24799256-4AE6D0CC-ACD7-46D9-B723-D5FBF28A6B4FQ26777195-BD902905-1FC1-413C-848F-EE206A01B4EBQ26796639-D1EF8B86-7CF3-4820-9FB6-7E6C6287FA68Q26827187-C989EE3A-43D7-4628-ACFF-3628C7DAC039Q27001581-D16BDAD3-E61A-4CA2-845E-D8E9AB22AB05Q27002611-7093B6D2-C37C-4AC6-BFBF-02EB0DF16C39Q27011462-7DBF5B20-B120-40F3-AEC4-9186A6E7ABDDQ27025559-084A30FF-4500-4912-BCB1-E0115463A52AQ27315131-8811BE09-54C6-40C2-8E5A-B0B20AA0C2EDQ27318543-2893D165-87E8-415E-A74B-4B07EC575F36Q27472755-C7E8CFA4-9FA8-415D-9755-2CF494CD7817Q27473048-B6580C99-EB69-4D7E-9B3F-3D528557D50EQ27477482-1848110B-6BF5-46A5-B3EB-7D125FF9800EQ27481222-D20D9647-305C-4153-838D-C04A898B8865Q27481501-97B85C4C-4627-4A69-AE50-DA0965591869Q27485133-B1AF2E66-0CA4-4571-BE40-67BC51CC1951Q27486783-D2EEAC7B-6539-4482-BABA-466658E0B78C
P2860
Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling
description
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Dezember 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/12/15)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/12/15)
@nl
наукова стаття, опублікована в грудні 2002
@uk
مقالة علمية (نشرت في 15-12-2002)
@ar
name
Cutting edge: a novel Toll/IL- ...... e Toll-like receptor signaling
@ast
Cutting edge: a novel Toll/IL- ...... e Toll-like receptor signaling
@en
Cutting edge: a novel Toll/IL- ...... e Toll-like receptor signaling
@nl
type
label
Cutting edge: a novel Toll/IL- ...... e Toll-like receptor signaling
@ast
Cutting edge: a novel Toll/IL- ...... e Toll-like receptor signaling
@en
Cutting edge: a novel Toll/IL- ...... e Toll-like receptor signaling
@nl
prefLabel
Cutting edge: a novel Toll/IL- ...... e Toll-like receptor signaling
@ast
Cutting edge: a novel Toll/IL- ...... e Toll-like receptor signaling
@en
Cutting edge: a novel Toll/IL- ...... e Toll-like receptor signaling
@nl
P2093
P3181
P1476
Cutting edge: a novel Toll/IL- ...... e Toll-like receptor signaling
@en
P2093
Katsuaki Hoshino
Kiyoshi Takeda
Kiyotoshi Mori
Masahiro Yamamoto
Osamu Takeuchi
Shintaro Sato
P304
P3181
P356
10.4049/JIMMUNOL.169.12.6668
P407
P50
P577
2002-12-15T00:00:00Z